Copyright
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Psychiatry. Apr 19, 2022; 12(4): 603-614
Published online Apr 19, 2022. doi: 10.5498/wjp.v12.i4.603
Published online Apr 19, 2022. doi: 10.5498/wjp.v12.i4.603
Dimensional (premenstrual symptoms screening tool) vs categorical (mini diagnostic interview, module U) for assessment of premenstrual disorders
Rifka Chamali, Department of Research, Weill Cornell Medicine - Qatar, Doha 00974, Qatar
Rana Emam, Department of Psychiatry, Hamad Medical Corporation, Doha 00974, Qatar
Ziyad R Mahfoud, Department of Medical Education, Weill Cornell Medicine - Qatar, Doha 00974, Qatar
Ziyad R Mahfoud, Division of Epidemiology, Department of Population of Health Sciences, Weill Cornell Medicine, New York 10065, NY, United States
Hassen Al-Amin, Department of Psychiatry, Weill Cornell Medicine - Qatar, Doha 00974, Qatar
Author contributions: Hassen A and Rana E designed the research; Rifka C performed the research; Ziyad M and Rifka C analyzed the data; all authors wrote the paper.
Supported by the Qatar National Research Fund , No. UREP 10-022-3-005 .
Institutional review board statement: The study protocol was approved by the Institutional Review Boards of Hamad Medical Corporation and Weill Cornell Medicine in Doha, Qatar. Written signed informed consent was waived because the research presented no more than minimal risk or harm to the participants.
Informed consent statement: All study participants, or their legal guardian, provided informed written consent prior to study enrollment.
Conflict-of-interest statement: The authors have no competing interests.
Data sharing statement: Technical appendix, statistical code, and dataset available from the corresponding author at haa2019@qatar-med.cornell.edu . The data available include no identifiers.
STROBE statement: The authors have read the STROBE Statement—checklist of items, and the manuscript was prepared and revised according to the STROBE Statement—checklist of items.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Hassen Al-Amin, MD, Professor, Department of Psychiatry, Weill Cornell Medicine - Qatar, Education City, AlRayyan Street, Doha 00974, Qatar. haa2019@qatar-med.cornell.edu
Received: March 28, 2021
Peer-review started: March 28, 2021
First decision: October 4, 2021
Revised: October 23, 2021
Accepted: April 1, 2022
Article in press: April 1, 2022
Published online: April 19, 2022
Processing time: 380 Days and 9.3 Hours
Peer-review started: March 28, 2021
First decision: October 4, 2021
Revised: October 23, 2021
Accepted: April 1, 2022
Article in press: April 1, 2022
Published online: April 19, 2022
Processing time: 380 Days and 9.3 Hours
Core Tip
Core Tip: This manuscript assesses the relationship between responses on the dichotomous the Mini international neuropsychiatric interview, module U (MINI-U) answers and the scores on the Premenstrual Symptoms screening tool (PSST). Our findings give reassurance that the MINI-U provides an adequate assessment for the probable diagnosis of Premenstrual dysphoric disorder (PMDD) and that the severity measures of the PSST can recognize patients with moderate/severe premenstrual syndrome and PMDD who would benefit from immediate treatment.